Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Celularity stock | $10.13

Learn how to easily invest in Celularity stock.

Celularity Inc is a shell companies business based in the US. Celularity shares (GXGX) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in Celularity

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – GXGX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Celularity stock price (NASDAQ: GXGX)

Use our graph to track the performance of GXGX stocks over time.

Celularity shares at a glance

Information last updated 2021-09-12.
Latest market close$10.13
52-week range$8.07 - $12.17
50-day moving average $10.06
200-day moving average $10.14
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.49

Buy Celularity shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Celularity stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Celularity price performance over time

Historical closes compared with the close of $10.13 from 2021-05-28

1 week (2021-10-05) N/A
1 month (2021-09-12) N/A
3 months (2021-07-16) -0.69%
6 months (2021-04-15) 0.30%
1 year (2020-10-15) -4.07%
2 years (2019-10-15) 2.01%
3 years (2018-10-12) N/A
5 years (2016-10-12) N/A

Celularity financials

Gross profit TTM $0
Return on assets TTM -1.29%
Return on equity TTM -52.61%
Profit margin 0%
Book value $0.67
Market capitalisation $201.6 million

TTM: trailing 12 months

Shorting Celularity shares

There are currently 760,441 Celularity shares held short by investors – that's known as Celularity's "short interest". This figure is 22.7% up from 619,740 last month.

There are a few different ways that this level of interest in shorting Celularity shares can be evaluated.

Celularity's "short interest ratio" (SIR)

Celularity's "short interest ratio" (SIR) is the quantity of Celularity shares currently shorted divided by the average quantity of Celularity shares traded daily (recently around 108945.70200573). Celularity's SIR currently stands at 6.98. In other words for every 100,000 Celularity shares traded daily on the market, roughly 6980 shares are currently held short.

However Celularity's short interest can also be evaluated against the total number of Celularity shares, or, against the total number of tradable Celularity shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Celularity's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Celularity shares in existence, roughly 40 shares are currently held short) or 0.0307% of the tradable shares (for every 100,000 tradable Celularity shares, roughly 31 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Celularity.

Find out more about how you can short Celularity stock.

Celularity share dividends

We're not expecting Celularity to pay a dividend over the next 12 months.

Celularity overview

Celularity Inc. , a biopharmaceutical company, develops placental-derived off-the-shelf therapeutic and cellular medicines for cancer, infectious diseases, and degenerative diseases. The company offers Biovance, a human amniotic membrane allograft that provides a protective cover and supports the body's wound healing processes; and Interfyl, a connective tissue matrix for various surgical applications when there is a need to replace and supplement damaged or inadequate integumental tissue. It also offers allogeneic placenta-derived cell therapy product candidates. The company was incorporated in 2016 and is based in Florham Park, New Jersey. .

Celularity in the news

There are no recent company news

Frequently asked questions

What percentage of Celularity is owned by institutions?
Currently 83.535% of Celularity shares are held by institutions.
When does the fiscal year end for Celularity?
Celularity's fiscal year ends in December.
Where is Celularity based?
Celularity's address is: 170 Park Ave, Florham Park, NJ, United States, 07932
What is Celularity's ISIN number?
Celularity's international securities identification number is: US1511901050

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site